pandem
influenza
viru
emerg
caus
consider
morbid
mortal
third
world
especi
brazil
although
circul
strain
virus
variou
studi
suggest
mutat
viral
hemagglutinin
ha
may
associ
enhanc
sever
fatal
phenomenon
particularli
challeng
immunocompromis
individu
undergon
bone
marrow
transplant
bmt
like
display
wors
clinic
outcom
influenza
infect
nonimmunocompromis
individu
studi
clinic
viral
aspect
postbmt
patient
confirm
diagnosi
largest
cancer
hospit
brazil
found
viral
strain
polymorph
ha
presum
virul
individu
despit
patient
show
mild
symptom
infect
find
complement
discoveri
mild
case
infect
viru
mutat
brazil
oppos
studi
link
chang
increas
diseas
sever
result
could
import
better
comprehens
impact
pandem
influenza
context
bmt
citat
mesquita
resend
p
marttorelli
machado
v
sacramento
cq
et
al
detect
influenza
viru
carri
mutat
patient
undergon
bone
marrow
transplant
plo
one
influenza
emerg
april
reach
develop
countri
dramat
brazil
influenza
surveil
neglect
death
occur
understand
impact
critic
import
patient
higher
risk
infect
immunocompromis
individu
cancer
transplant
patient
atyp
clinic
present
influenzalik
ill
ili
may
delay
adequ
clinic
intervent
lead
wors
clinic
outcom
brazil
death
occur
immunocompromis
individu
addit
predispos
condit
host
specif
polymorph
viral
genom
could
enhanc
viral
virul
although
major
antigen
variat
hemagglutinin
ha
circul
strain
found
sever
polymorph
strain
describ
constitut
seven
clade
base
concaten
viral
genom
sequenc
ha
segment
reproduc
phylogenet
topolog
presum
virul
clade
virus
south
america
virus
clade
cocircul
polymorph
found
clade
strain
identifi
includ
mutat
esh
strain
controversi
interpret
esh
strainrel
morbid
mortal
rais
potdar
et
al
found
posit
associ
clade
virus
death
glinski
et
al
state
individu
die
due
infect
variant
carri
mutat
howev
esh
strain
found
mild
case
reinforc
fact
hostspecif
factor
could
also
account
influenzarel
clinic
outcom
consid
inform
suggest
sever
impact
esh
strain
gener
popul
may
expect
strain
could
potenti
lifethreaten
immunocompromis
individu
studi
phylogenet
relev
chang
ha
viru
individu
undergon
bonemarrow
transplant
bmt
despit
found
benign
clinic
outcom
strengthen
previou
find
brazilian
popul
infect
esh
strain
studi
approv
ethic
committe
de
tica
em
pesquisa
cep
http
wwwincagovbr
conteudoviewasp
id
instituto
nacion
de
inca
rio
de
janeiro
brazil
institut
review
board
led
dr
adriana
scheliga
protocol
submit
number
need
inform
consent
waiv
sampl
clinic
data
pandem
nation
refer
center
bmt
centro
de
transplant
de
medula
ssea
cemo
nation
cancer
institut
inca
rio
de
janeiro
brazil
sent
laboratori
part
influenza
surveil
brazilian
nation
influenza
center
minim
requir
inclus
retrospect
analysi
conveni
sampl
fever
ili
previou
histori
bmt
june
august
nasopharyng
swab
npa
patient
collect
patient
confirm
diagnosi
tabl
besid
case
analysi
two
control
group
patient
includ
individu
confirm
diagnosi
influenza
date
onset
ill
epidemiolog
week
repres
period
time
mitig
phase
pandem
august
th
issu
recommend
postpandem
period
sampl
collect
pandem
numer
clinicalepidemiolog
form
entir
fulfil
nevertheless
sequenc
sampl
complet
clinic
inform
presenc
comorbid
immun
statu
presenc
sever
acut
respiratori
infect
sari
requir
hospit
clinic
outcom
nasopharyng
dacron
swab
aspir
npa
collect
rna
extract
use
viral
rna
mini
kit
qiagen
ca
accord
manufactur
instruct
rna
elut
mm
trishcl
ph
mm
edta
te
buffer
store
rna
use
onestep
realtim
rtpcr
assay
influenza
subtyp
accord
world
health
organis
recommend
diagnosi
rang
respiratori
pathogen
coronaviru
parainfluenza
human
metapneumoviru
parechoviru
rhinoviru
rsv
ab
adenoviru
enteroviru
perform
accord
manufactur
instruct
fast
track
diagnosi
luxemburg
luxemburg
madindarbi
canin
kidney
mdck
cell
cultur
dulbecco
modifi
eagl
medium
dmem
gibco
grand
island
ny
supplement
fetal
bovin
serum
fb
hyclon
logan
utah
uml
penicillin
mgml
streptomycin
incub
co
viru
isol
perform
either
embryon
egg
mdck
cell
previous
describ
confirm
viral
isol
use
hemagglutin
neuraminidas
activ
realtim
rtpcr
assay
virus
passag
three
time
influenza
ha
gene
sequenc
sanger
protocol
describ
elsewher
brief
rna
patient
npa
extract
viral
rna
mini
kit
qiagen
ca
subject
onestep
rtpcr
use
superscript
iii
platinum
taq
previous
describ
primer
amplicon
purifi
sequenc
sanger
method
big
dye
termin
cycl
sequenc
readi
reaction
kit
appli
biosystem
ca
fragment
analyz
use
automat
sequenc
abi
prismtm
genet
analyz
pe
appli
biosystem
consensu
sequenc
ha
gener
seqe
appli
biosystem
align
sequenc
deposit
genbank
use
clustalw
algorithm
megalign
mega
softwar
product
analys
abi
prism
genet
analys
life
technolog
dataset
gener
assembl
sequench
softwar
genecod
corpor
michigan
usa
ha
refer
sequenc
genbank
access
number
note
number
use
ha
throughout
studi
sequenc
analyz
use
neighborjoin
bootstrap
time
mega
softwar
note
number
use
ha
throughout
studi
genbank
access
number
sequenc
gener
articl
follow
amplifi
rtpcr
product
purifi
use
qiaquick
pcr
purif
kit
qiagen
valencia
ca
sequenc
use
bigdy
termin
cycl
sequenc
kit
life
technolog
ca
standard
descript
statist
use
describ
studi
popul
continu
variabl
report
mean
standard
deviat
median
rang
appropri
compar
analys
postbmt
patient
control
group
nonimunocompromis
individu
mild
outcom
otherwis
healthi
adult
severefat
outcom
perform
use
openepi
softwar
signific
access
fischer
exact
test
p
valu
odd
ratio
confid
interv
ci
regist
appropri
postbmt
patient
studi
median
age
year
rang
year
male
account
individu
patient
underw
bmt
within
month
diagnosi
stratifi
time
frame
critic
immunosuppress
bmt
two
immunosuppress
patient
one
graftversushost
diseas
gvhd
chronic
lung
injuri
cli
receiv
bmt
month
prior
influenza
diagnosi
tabl
seven
patient
receiv
bmt
month
prior
influenza
infect
tabl
howev
two
patient
last
group
immunocompromis
due
remiss
cancer
chronic
neutropenia
cellsmm
tabl
virus
infect
patient
infecti
isol
cell
cultur
although
search
respiratori
virus
infect
patient
neg
fasttrack
diagnost
luxembourg
luxembourg
ha
sequenc
clinic
sampl
eight
case
mutant
virus
found
esh
strain
found
patient
one
sampl
mutat
figur
anoth
patient
strain
wildtyp
wt
residu
mutant
detect
ksq
strain
patient
tabl
predispos
condit
patient
indic
like
wors
clinic
outcom
addit
confirm
diagnosi
presum
virul
strain
could
even
critic
individu
despit
patient
display
mild
symptom
infect
hospit
requir
comparison
influenza
ha
sequenc
postbmt
patient
lee
et
al
control
group
otherwis
healthi
individu
severefat
outcom
nonimmunocompromis
individu
mild
infect
shown
figur
see
specif
pattern
cluster
sequenc
togeth
figur
fact
phylogenet
tree
low
bootstrap
valu
differ
branch
figur
suggest
independ
clinic
outcom
andor
predispos
condit
differ
viru
strain
period
look
alik
next
compar
exposur
viru
carri
three
polymorph
esh
strain
risk
factor
lead
differ
outcom
postbmt
individu
control
group
patient
note
anoth
requir
control
would
viral
strain
without
three
polymorph
dataset
virus
genet
closer
also
carri
chang
mutat
found
influenza
virus
clade
brazilian
strain
mitig
phase
pandem
afterward
sinc
mutat
main
one
associ
increas
influenza
virul
comparison
esh
ksq
strain
correl
diseas
sever
could
still
feasibl
select
brazilian
sampl
pandem
period
dataset
found
sequenc
sampl
potenti
control
group
among
case
healthi
individu
regist
inform
absenc
comorbid
case
nonimmunocompromis
individu
among
healthi
individu
mild
infect
esh
viru
detect
sever
infect
esh
virus
deceas
esh
viru
nonimmunocompromis
individu
mild
outcom
esh
virus
sever
infect
esh
virus
deceas
esh
virus
tabl
compar
esh
risk
factor
ksq
strain
postbmt
patient
group
although
esh
presum
lethal
mild
clinic
outcom
like
occur
postbmt
patient
sever
fatal
outcom
otherwis
healthi
individu
ci
p
tabl
upper
half
exposur
esh
analyz
compar
two
group
mild
outcom
postbmt
vs
nonimmunocompromis
patient
signific
differ
observ
tabl
lower
half
despit
greater
tendenc
eshinfect
postbmt
patient
progress
mild
clinic
infect
nonimmunocompromis
individu
ci
altogeth
data
phylogenet
tree
conting
tabl
suggest
esh
strain
correl
sever
fatal
may
question
find
oppos
previous
observ
impact
esh
strain
gener
popul
patient
easili
distinguish
term
specif
genet
background
ethnic
previou
histori
treatment
clinic
intervent
therefor
seem
unlik
impair
viru
replic
could
occur
consequ
specif
canceror
bmtrelat
intervent
although
work
influenza
infect
postbmt
patient
gener
limit
small
number
patient
around
dozen
individu
contribut
import
metaanalysi
investig
may
strengthen
isol
find
display
literatur
associ
clinic
data
viral
sequenc
import
identif
novel
virul
marker
although
approach
use
surveil
take
host
genet
background
grant
believ
surveil
focus
immunocompromis
patient
could
mani
case
yield
pragmat
insight
public
health
concern
postbmt
patient
tend
wors
clinic
outcom
due
influenza
infect
identif
mild
symptom
presum
virul
viru
could
mean
enhanc
pathogen
variant
question
specif
factor
associ
popul
may
impair
viru
infect
replic
respect
esh
strain
find
complement
studi
graham
et
al
lee
et
al
oppos
glinski
et
al
potdar
et
al
esh
strain
may
includ
clade
influenza
associ
morbid
mortal
nevertheless
virus
possess
mutat
gene
ha
could
natur
influenc
virul
glinski
et
al
found
exceedingli
high
preval
mutat
individu
deceas
base
sole
last
work
associ
mortal
would
even
signific
one
present
chang
viral
ha
taken
account
esh
strain
may
simpli
emerg
peak
pandem
influenza
circul
esh
strain
detect
mild
case
pandem
viru
infect
us
other
differ
countri
studi
brazilian
sampl
period
lee
colleagu
suggest
rather
real
phenotyp
chang
could
increas
influenza
virul
esh
strain
emerg
stochast
event
peak
viru
circul
brazilian
winter
therefor
agre
interpret
increas
mortal
hospit
brazil
epidemiolog
week
due
enhanc
influenza
circul
predispos
host
emerg
esh
strain
demonstr
major
event
led
influenza
morbid
mortal
includ
otherwis
healthi
individu
suscept
human
popul
influenza
virus
low
glycosyl
ha
influenza
nevertheless
accumul
global
data
differ
cohortsgroup
patient
need
reach
decis
conclus
import
mutat
final
result
could
stimul
debat
among
investig
work
molecular
epidemiologysurveil
influenza
critic
mutat
strain
could
interest
physician
work
bmt
